Operating Cash Flow (Statement)

-$7.24M

Quarterly · Period ending: Jun 30, 2026 · USD

Latest reported-$7.24Mperiod endingJun 30, 2026

LCTX Quarterly Cash from Operations (-$100.00K → -$7.24M)

Quarterly operating cash flow (statement)

High-resolution chart · PNG

LCTX operating cash flow (statement) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Lineage Cell Therapeutics, Inc. Common Stock Operating Cash Flow (Statement) — Quarterly (USD)
Period ending	Operating Cash Flow (Statement) (USD)
Jun 30, 2001	-807,772
Mar 31, 2001	-1,011,849
Dec 31, 2000	-858,475
Sep 30, 2000	-1,161,439
Jun 30, 2000	-1,239,190
Mar 31, 2000	-1,597,926
Dec 31, 1999	-1,294,901
Sep 30, 1999	-500,000
Jun 30, 1999	-1,400,000
Mar 31, 1999	-1,200,000
Sep 30, 1998	-1,200,000
Jun 30, 1998	-1,000,000
Mar 31, 1998	-1,200,000
Dec 31, 1997	-1,200,000
Sep 30, 1997	-1,000,000
Jun 30, 1997	500,000
Mar 31, 1997	-700,000
Dec 31, 1996	-500,000
Sep 30, 1996	-600,000
Sep 30, 1995	-600,000
Jun 30, 1995	-400,000
Mar 31, 1995	-500,000
Dec 31, 1994	-600,000
Sep 30, 1994	-500,000
Jun 30, 1994	-600,000
Mar 31, 1994	-300,000
Dec 31, 1993	-400,000
Sep 30, 1993	-300,000
Jun 30, 1993	-400,000
Mar 31, 1993	-300,000
Dec 31, 1992	-300,000
Sep 30, 1992	-300,000
Jun 30, 1992	-100,000